Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$361M |
| 2 |
CVS Health
CVS
|
+$180M |
| 3 |
Cigna
CI
|
+$158M |
| 4 |
Microsoft
MSFT
|
+$102M |
| 5 |
Amazon
AMZN
|
+$90M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ESRX
Express Scripts Holding Company
ESRX
|
+$301M |
| 2 |
AET
Aetna Inc
AET
|
+$270M |
| 3 |
PX
Praxair Inc
PX
|
+$184M |
| 4 |
ANDV
Andeavor
ANDV
|
+$97.3M |
| 5 |
COL
Rockwell Collins
COL
|
+$89M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.86% |
| 2 | Financials | 13.99% |
| 3 | Healthcare | 13.63% |
| 4 | Industrials | 10.39% |
| 5 | Consumer Discretionary | 9.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2926
Spyre Therapeutics
SYRE
$8.54B
| $309K | ﹤0.01% |
1,646
+434
| +36% | +$92.1K |
|
2927
Oil-Dri
ODC
$1.44B
| $308K | ﹤0.01% |
23,174
| – | – |
|
|
SIFI
2928
DELISTED
SI Financial Group, Inc. NEW MD
SIFI
| $307K | ﹤0.01% |
24,087
| – | – |
|
2929
First Community Corp
FCCO
$321M
| $306K | ﹤0.01% |
15,704
| – | – |
|
2930
Ardmore Shipping
ASC
$710M
| $305K | ﹤0.01% |
65,290
| – | – |
|
|
FONR
2931
DELISTED
Fonar
FONR
| $305K | ﹤0.01% |
15,031
+1,891
| +14% | +$42.6K |
|
|
MBCN
2932
DELISTED
Middlefield Banc Corp
MBCN
| $304K | ﹤0.01% |
14,288
+1,700
| +14% | +$38.2K |
|
2933
Lifetime Brands
LCUT
$191M
| $303K | ﹤0.01% |
30,133
+9,013
| +43% | +$95.1K |
|
2934
Parke Bancorp
PKBK
$401M
| $303K | ﹤0.01% |
17,797
| – | – |
|
|
FLNT
2935
Fluent
FLNT
$102M
| $301K | ﹤0.01% |
13,897
+1,947
| +16% | +$35.5K |
|
2936
NCS Multistage Holdings
NCSM
$123M
| $301K | ﹤0.01% |
2,952
-473
| -14% | -$90.8K |
|
|
FTSV
2937
DELISTED
Forty Seven, Inc. Common Stock
FTSV
| $300K | ﹤0.01% |
19,050
+3,550
| +23% | +$54.2K |
|
2938
EVI Industries
EVI
$181M
| $297K | ﹤0.01% |
8,896
| – | – |
|
2939
Stagwell
STGW
$2.09B
| $297K | ﹤0.01% |
113,743
+11,603
| +11% | +$33K |
|
2940
LoveSac
LOVE
$236M
| $296K | ﹤0.01% |
+12,880
| New | +$267K |
|
|
RVLP
2941
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
| $296K | ﹤0.01% |
+38,074
| New | +$305K |
|
|
KZR
2942
DELISTED
Kezar Life Sciences
KZR
| $295K | ﹤0.01% |
1,249
+272
| +28% | +$66.5K |
|
2943
Orrstown Financial Services
ORRF
$840M
| $295K | ﹤0.01% |
16,174
| – | – |
|
2944
Funko
FNKO
$326M
| $294K | ﹤0.01% |
22,300
| – | – |
|
2945
eGain
EGAN
$187M
| $292K | ﹤0.01% |
44,420
+11,520
| +35% | +$83.7K |
|
|
TNAV
2946
DELISTED
Telenav Inc.
TNAV
| $292K | ﹤0.01% |
71,809
| – | – |
|
2947
Ascent Industries
ACNT
$140M
| $291K | ﹤0.01% |
17,500
| – | – |
|
2948
Ocular Therapeutix
OCUL
$1.79B
| $289K | ﹤0.01% |
72,559
| – | – |
|
|
LBY
2949
DELISTED
Libbey, Inc.
LBY
| $289K | ﹤0.01% |
74,255
-13,372
| -15% | -$86.9K |
|
|
UBFO
2950
DELISTED
United Security Bancshares
UBFO
| $288K | ﹤0.01% |
30,023
+2,700
| +10% | +$28.3K |
|
Similar funds
Charles Schwab's Q4 2018 Portfolio in Review
As of Q4 2018, Charles Schwab held 3,199 positions worth $131B, down 13% from $150B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Trading was light in Q4 2018: portfolio turnover was 3.8%. Charles Schwab opened 67 new positions and exited 53, leaving the 3,199-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2018 buy was Linde: 2,286,208 shares worth $357M.
- Charles Schwab added most to CVS Health in Q4 2018, an estimated $180M increase.
- Charles Schwab's biggest Q4 2018 reduction was Qualcomm, cutting an estimated $42.7M.
- Charles Schwab fully exited Express Scripts Holding Company in Q4 2018, selling an estimated $301M.
- Charles Schwab's ten largest holdings make up 15% of its $131B portfolio in Q4 2018.
- Charles Schwab opened 67 new positions and closed 53 in Q4 2018.
- Charles Schwab's portfolio value fell 13% quarter-over-quarter to $131B.
Based on Charles Schwab's 13F filing for Q4 2018, filed 14 Feb 2019.